The symptoms that stick around: Quebec researchers examine persistent symptoms following Omicron infection Study identifies risk factors and prevalence of ongoing symptoms after SARS-CoV-2 Omicron infection in adults. Post lockdown sees a 37% jump in asthma- and COPD-related ED visits But rebound varies by age with asthmatic children under 5 years seeing an 81% jump in study at Missouri hospitals. Omalizumab in the treatment of asthma: a long-term study First report to assess asthma control upon medication discontinuation in a large cohort of adult and pediatric patients. Getting beyond ‘voluntourism’ Finding the right medical mission and doing it for the right reasons takes research—and some self-reflection. Close to half of AMD patients using aflibercept can be weaned off eye injections While those getting bevacizumab got more injections, improvements were similar. Long-acting injectable PrEP is a big step forward in HIV prevention After successful clinical trials, long-acting cabotegravir was found to be almost 100% effective at preventing HIV. Yoga beneficial in lowering blood pressure: study Adding yoga to regular exercise can lower systolic pressure and improve cardiovascular risk, research shows. Is it feasible to control sugar consumption? According to Dr. Noorali Bharwani, sugar is one temptation we can do without. One in three South Asians with ASCVD on statins are eligible for icosapent ethyl Icosapent ethyl should be considered for this high-risk population. Study shows importance of COVID-19 vaccine booster dose in children 5 to 11 years A booster dose of Pfizer vaccine restored protection against Omicron, with efficacy maintained for at least three months. First Previous 81 82 83 84 85 Next Last
